Mental Health Awareness Week
Mental Health Awareness Week is coming to a close and this year’s focus has been body image. There has also been an abundance of focus on the commonality of mental health issues such as depression and anxiety as well as a renewed encouragement of our society to normalise mental health, to see it in as […]
The new vision for community pharmacy and its role in the NHS
Real transformation will be needed to fulfil the NHS vision for community pharmacy and its role in healthcare provision for the future, say the Pharmaceutical Services Negotiating Committee (PSNC). Outlined in a video animation, the PSNC highlight the importance of pharmacy’s current work whilst detailing the transformation that community pharmacy is expected to undergo in […]
Ocrelizumab now available for those with primary progressive MS
Ocrelizumab, the first disease-modifying treatment (DMT) to be proven in slowing down the progression of primary progressive multiple sclerosis (PPMS), has finally been signed off for use at a clinical level. The DMT has been licensed for relapsing-remitting (RR) MS for almost a year, but despite being the first drug to show efficacy in the […]
Headache telehealth advance gets funded as part of NHS long term plan
The NHS has announced its plans to fund exciting new technology to treat excruciating headache as part of the Long Term Plan. The handheld device, which uses low-level electrical currents to disrupt pain signals is an innovative treatment for cluster headaches, a particularly painful form of headache affecting around 66,000 people in the UK. Those […]
A new type of dementia is identified
A team of researchers at the University of Kentucky have identified a new type of dementia, ‘LATE’ which until now may have been being wrongly diagnosed as Alzheimer’s disease. LATE, or limbic-predominant age-related TDP-43 encephalopathy, has been linked with the brain protein TDP-43, and may be the dementia type experienced by up to a third […]
Neurology Academy in the BJNN
The British Journal for Neuroscience Nursing (BJNN) have just published a piece on the national drive to address unwanted variance in multiple sclerosis (MS) services. The project was initiated at ‘the Way Forward’ event last year when the MS Academy, part of Neurology Academy’s umbrella organisation, organised and hosted a lively two day conference full […]
The Neurology Academy’s expanding influence
The Neurology Academy has come a long way in the past few years, ballooning from a single offering of MasterClasses in Parkinson’s to an extensive offering of educational courses spanning disease areas and tailored to different levels of learning. Recently that offering has diversified into cross-conditional topics like palliative care and neuropharmacy, and seen a […]
Early research suggests groundbreaking changes afoot for Parkinson’s
Parkinson’s is a neurological condition that affects many elements of day to day functionality, changing a person’s experience of their everyday life. One of these elements is movement, with freezing, stumbling and falling all common symptoms of Parkinson’s. A recent pilot study in Canada has seen some radical changes in patient’s walking, resulting from electrical […]
Our first Neuropharmacy MasterClass
In January this year, we ran our first ever Neuropharmacy MasterClass. The growing specialism is a complex and wide-ranging one, covering a vast range of roles and responsibilities, and this was fully reflected in our packed and practical programme. As Professor Gavin Giovannoni points out, the role of the pharmacist has evolved as the complexity […]
Getting prepped – where will your project take you?
The Neurology Academy’s unique blend of education puts a heavy emphasis on the practical, and integral to our Parkinson’s Advanced MasterClasses is the inter-module project. For some this can be an exciting opportunity to get stuck into an audit, or service development project that they have been waiting impatiently to carry out, but for others it […]
